Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemostasis in liver resection surgery.

J Peter A Lodge1

  • 1HPB and Transplant Unit, St. James University Hospital, Leeds, UK.

Seminars in Hematology
|February 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of incidental gallbladder cancer in a nationwide CAPBIL study.

The British journal of surgery·2026
Same author

Adherence to best practice guidelines for the management of intrahepatic cholangiocarcinoma: results from the CAPBIL study.

The British journal of surgery·2026
Same author

Evolving patterns of adjuvant chemotherapy and survival after surgery for peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study.

The British journal of surgery·2025
Same author

Somatostatin peptides prevent increased human colonic epithelial permeability induced by hypoxia.

American journal of physiology. Gastrointestinal and liver physiology·2024
Same author

Changing perspectives in the treatment of colorectal liver metastases.

The British journal of surgery·2024
Same author

Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis.

Journal of hepatology·2023
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Advances in liver resection techniques and hemostatic agents like recombinant factor VIIa (rFVIIa) aim to improve outcomes for challenging liver tumor surgeries. These innovations focus on creating bloodless fields and reducing transfusions during major liver resections.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Transfusion Medicine

Background:

  • Liver tumors present significant surgical challenges, but advancements are making previously unresectable cases manageable.
  • New surgical techniques like in situ hypothermic perfusion, ante situm technique, and ex vivo liver resection offer improved dissection and bloodless fields.
  • Managing blood loss and transfusion requirements remains a critical aspect of major liver resection surgery.

Purpose of the Study:

  • To review recent advancements in liver resection procedures for challenging liver tumors.
  • To evaluate the role of recombinant factor VIIa (rFVIIa) in reducing red blood cell transfusions during major liver surgery.
  • To discuss current and future hemostatic management strategies in liver resection.

Main Methods:

Related Experiment Videos

  • Review of novel surgical techniques including in situ hypothermic perfusion, ante situm technique, and ex vivo liver resection.
  • Analysis of clinical trial data on the use of recombinant factor VIIa (rFVIIa) for hemostasis.
  • Discussion of established and emerging methods for hemostasis management in liver surgery.

Main Results:

  • New surgical techniques facilitate prolonged, precise dissections in bloodless fields.
  • Recombinant factor VIIa (rFVIIa) shows potential in decreasing the need for red blood cell transfusions during major liver resections.
  • Ongoing research aims to optimize hemostasis control in complex liver surgeries.

Conclusions:

  • Liver resection is becoming feasible for a wider range of tumors due to procedural innovations.
  • Recombinant factor VIIa (rFVIIa) represents a promising adjunct for managing hemostasis and reducing transfusion needs.
  • Effective hemostasis management is crucial for improving patient outcomes in liver tumor surgery.